Screener
CVS Health CVS Products — Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by CVS Health in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: CVS Health’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 6:33 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000064803-26-000052
| In millions, except per share amounts | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Revenues: | ||
| Products | $62,226 | $57,669 |
| Premiums | 33,791 | 32,820 |
| Services | 3,835 | 3,579 |
| Net investment income | 574 | 520 |
| Total revenues | 100,426 | 94,588 |
| Operating costs: | ||
| Cost of products sold | 55,444 | 51,057 |
Item 1.Financial Statements
FAQ
- What is CVS Health's products — revenue?
- CVS Health (CVS) reported products — revenue of $62.23B in Q1 2026.
- How has CVS Health's products — revenue changed year-over-year?
- CVS Health's products — revenue increased by 7.9% year-over-year, from $57.67B to $62.23B.
- What is the long-term trend for CVS Health's products — revenue?
- Over 4 years (2021 to 2025), CVS Health's products — revenue has grown at a 5.2% compound annual growth rate (CAGR), from $203.74B to $249.91B.
- What does products — revenue mean?
- This metric represents the total gross sales generated from the sale of pharmaceutical products, over-the-counter health items, and related retail merchandise. It captures the top-line performance of the company's core pharmacy and retail operations before the deduction of operating expenses or cost of goods sold. This segment is a primary driver of cash flow and serves as a critical indicator of consumer demand and retail footprint productivity.
Ask your AI about CVS Health's products — revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude